Skip to main content
PMC home page
Netherlands Heart Journal logoLink to Netherlands Heart Journal
. 2006 Dec;14(12):409–416.

Cardiac complications in type 2 diabetic patients with mild anginal symptoms and documented reversible myocardial perfusion defects

Results of the MERIDIAN trial

JJ Wiersma, LM Dijksman, WL ten Holt, JM Radder, HJ Verberne, BLF van Eck-Smit, MD Trip, TGV Cherpanath, PHJM Dunselman, JGP Tijssen, JJ Piek
PMCID: PMC2557327  PMID: 25696581

Abstract

Background/Objective

To compare early invasive treatment with continued pharmacological treatment in patients with diabetes mellitus type 2, mild anginal symptoms and documented myocardial ischaemia.

Methods

Patients with type 2 diabetes mellitus and mild anginal symptoms underwent myocardial perfusion scintigraphy (MPS). Patients with myocardial ischaemia were randomly assigned to early invasive or continued pharmacological treatment. All patients were followed for the occurrence of MACE (death, nonfatal myocardial infarction or hospitalisation for unstable angina pectoris).

Results

A total of 156 patients were randomised when the sponsor (ZonMW) prematurely terminated the study because of a slow recruitment rate. With a mean follow-up of 2.1±0.6 years, 9 of 79 patients assigned to early invasive treatment developed MACE compared with 10 of 77 patients randomised to continued pharmacological treatment, annual event rate 5.4 vs. 6.3%, hazard ratio 0.89, 95% CI 0.36 to 2.20, p=0.34. Due to the limited number of included patients and the low event rate, the study did not have sufficient power for the study objective.

Conclusion

Patients with diabetes mellitus type 2, mild anginal symptoms and documented myocardial ischaemia, under appropriate medical treatment, have a lower than anticipated annual event rate of MACE of ±5 to 6% which questions the beneficial effect of early revascularisation.

Keywords: diabetes mellitus type 2, angina pectoris, randomised controlled trials, myocardial revascularisation, drug therapy

Full text

PDF
412

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cerqueira Manuel D., Weissman Neil J., Dilsizian Vasken, Jacobs Alice K., Kaul Sanjiv, Laskey Warren K., Pennell Dudley J., Rumberger John A., Ryan Thomas, Verani Mario S. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539–542. doi: 10.1161/hc0402.102975. [DOI] [PubMed] [Google Scholar]
  2. Collins Rory, Armitage Jane, Parish Sarah, Sleigh Peter, Peto Richard, Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003 Jun 14;361(9374):2005–2016. doi: 10.1016/s0140-6736(03)13636-7. [DOI] [PubMed] [Google Scholar]
  3. Davies R. F., Goldberg A. D., Forman S., Pepine C. J., Knatterud G. L., Geller N., Sopko G., Pratt C., Deanfield J., Conti C. R. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997 Apr 15;95(8):2037–2043. doi: 10.1161/01.cir.95.8.2037. [DOI] [PubMed] [Google Scholar]
  4. Detre K. M., Guo P., Holubkov R., Califf R. M., Sopko G., Bach R., Brooks M. M., Bourassa M. G., Shemin R. J., Rosen A. D. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999 Feb 9;99(5):633–640. doi: 10.1161/01.cir.99.5.633. [DOI] [PubMed] [Google Scholar]
  5. Dibra Alban, Kastrati Adnan, Mehilli Julinda, Pache Jürgen, Schühlen Helmut, von Beckerath Nicolas, Ulm Kurt, Wessely Rainer, Dirschinger Josef, Schömig Albert. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005 Aug 16;353(7):663–670. doi: 10.1056/NEJMoa044372. [DOI] [PubMed] [Google Scholar]
  6. Elhendy Abdou, Huurman Aukje, Schinkel Arend F. L., Bax Jeroen J., van Domburg Ron T., Valkema Roelf, Biagini Elena, Poldermans Don. Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus. J Nucl Med. 2005 Oct;46(10):1589–1595. [PubMed] [Google Scholar]
  7. Feit F., Brooks M. M., Sopko G., Keller N. M., Rosen A., Krone R., Berger P. B., Shemin R., Attubato M. J., Williams D. O. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation. 2000 Jun 20;101(24):2795–2802. doi: 10.1161/01.cir.101.24.2795. [DOI] [PubMed] [Google Scholar]
  8. Gibbons Raymond J., Balady Gary J., Bricker J. Timothy, Chaitman Bernard R., Fletcher Gerald F., Froelicher Victor F., Mark Daniel B., McCallister Ben D., Mooss Aryan N., O'Reilly Michael G. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 1;106(14):1883–1892. doi: 10.1161/01.cir.0000034670.06526.15. [DOI] [PubMed] [Google Scholar]
  9. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999 Aug 21;354(9179):617–621. [PubMed] [Google Scholar]
  10. Haffner S. M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998 Jul 23;339(4):229–234. doi: 10.1056/NEJM199807233390404. [DOI] [PubMed] [Google Scholar]
  11. Held C., Björkander I., Forslund L., Rehnqvist N., Hjemdahl P. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris. Diabet Med. 2005 Oct;22(10):1326–1333. doi: 10.1111/j.1464-5491.2005.01643.x. [DOI] [PubMed] [Google Scholar]
  12. Hueb Whady, Soares Paulo R., Gersh Bernard J., César Luiz A. M., Luz Protásio L., Puig Luiz B., Martinez Eulógio M., Oliveira Sergio A., Ramires José A. F. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004 May 19;43(10):1743–1751. doi: 10.1016/j.jacc.2003.08.065. [DOI] [PubMed] [Google Scholar]
  13. Kannel W. B., McGee D. L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979 Mar-Apr;2(2):120–126. doi: 10.2337/diacare.2.2.120. [DOI] [PubMed] [Google Scholar]
  14. Keech Anthony, Colquhoun David, Best James, Kirby Adrienne, Simes R. John, Hunt David, Hague Wendy, Beller Elaine, Arulchelvam Manjula, Baker Jennifer. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes Care. 2003 Oct;26(10):2713–2721. doi: 10.2337/diacare.26.10.2713. [DOI] [PubMed] [Google Scholar]
  15. King H., Aubert R. E., Herman W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414–1431. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
  16. Marso S. P., Lincoff A. M., Ellis S. G., Bhatt D. L., Tanguay J. F., Kleiman N. S., Hammoud T., Booth J. E., Sapp S. K., Topol E. J. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation. 1999 Dec 21;100(25):2477–2484. doi: 10.1161/01.cir.100.25.2477. [DOI] [PubMed] [Google Scholar]
  17. Mehta S. R., Yusuf S., Peters R. J., Bertrand M. E., Lewis B. S., Natarajan M. K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001 Aug 18;358(9281):527–533. doi: 10.1016/s0140-6736(01)05701-4. [DOI] [PubMed] [Google Scholar]
  18. Miettinen H., Lehto S., Salomaa V., Mähönen M., Niemelä M., Haffner S. M., Pyörälä K., Tuomilehto J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998 Jan;21(1):69–75. doi: 10.2337/diacare.21.1.69. [DOI] [PubMed] [Google Scholar]
  19. Moss S. E., Klein R., Klein B. E. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991 Sep;81(9):1158–1162. doi: 10.2105/ajph.81.9.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parisi A. F., Folland E. D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992 Jan 2;326(1):10–16. doi: 10.1056/NEJM199201023260102. [DOI] [PubMed] [Google Scholar]
  21. Sever Peter S., Poulter Neil R., Dahlöf Björn, Wedel Hans, Collins Rory, Beevers Gareth, Caulfield Mark, Kjeldsen Sverre E., Kristinsson Arni, McInnes Gordon T. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care. 2005 May;28(5):1151–1157. doi: 10.2337/diacare.28.5.1151. [DOI] [PubMed] [Google Scholar]
  22. Smith S. C., Jr, Dove J. T., Jacobs A. K., Kennedy J. W., Kereiakes D., Kern M. J., Kuntz R. E., Popma J. J., Schaff H. V., Williams D. O. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001 Jun 15;37(8):2215–2239. doi: 10.1016/s0735-1097(01)01344-4. [DOI] [PubMed] [Google Scholar]
  23. Sobel Burton E., Frye Robert, Detre Katherine M., Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation. 2003 Feb 4;107(4):636–642. doi: 10.1161/01.cir.0000048897.03553.e4. [DOI] [PubMed] [Google Scholar]
  24. Stamler J., Vaccaro O., Neaton J. D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434–444. doi: 10.2337/diacare.16.2.434. [DOI] [PubMed] [Google Scholar]
  25. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A. M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994 Jul;90(1):583–612. doi: 10.1161/01.cir.90.1.583. [DOI] [PubMed] [Google Scholar]
  26. Unal Belgin, Critchley Julia Alison, Capewell Simon. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004 Mar 1;109(9):1101–1107. doi: 10.1161/01.CIR.0000118498.35499.B2. [DOI] [PubMed] [Google Scholar]
  27. Wackers Frans J. Th, Young Lawrence H., Inzucchi Silvio E., Chyun Deborah A., Davey Janice A., Barrett Eugene J., Taillefer Raymond, Wittlin Steven D., Heller Gary V., Filipchuk Neil. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004 Aug;27(8):1954–1961. doi: 10.2337/diacare.27.8.1954. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES